Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice

详细信息    查看全文

• 作者：Meifang Yu ; Yuan Qiu ; Jiming Chen ; Wenming Jiang
• 关键词：PRRSV ; DNA vaccine ; GP5 glycoprotein ; Recombinant adenovirus
• 刊名：Virus Genes
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：52
• 期：2
• 页码：228-234
• 全文大小：405 KB
• 参考文献：1.K.K. Conzelmann, N. Visser, P. Van Woensel, H.J. Thiel, Virology 193, 329–339 (1993)CrossRef PubMed
  2.Y. Li, X. Wang, K. Bo, X. Wang, B. Tang, B. Yang, W. Jiang, P. Jiang, Vet. J. 174, 577–584 (2007)CrossRef PubMed
  3.G.Z. Tong, Y.J. Zhou, X.F. Hao, Z.J. Tian, T.Q. An, H.J. Qiu, Emerg. Infect. Dis. 13, 1434–1436 (2007)CrossRef PubMed PubMedCentral
  4.Y.J. Zhou, X.F. Hao, Z.J. Tian, G.Z. Tong, D. Yoo, T.Q. An, T. Zhou, G.X. Li, H.J. Qiu, T.C. Wei, X.F. Yuan, Transbound. Emerg. Dis. 55, 152–164 (2008)CrossRef PubMed
  5.S. Dea, C.A. Gagnon, H. Mardassi, B. Pirzadeh, D. Rogan, Arch. Virol. 145, 659–688 (2000)CrossRef PubMed
  6.A.E. Firth, J.C. Zevenhoven-Dobbe, N.M. Wills, Y.Y. Go, U.B. Balasuriya, J.F. Atkins, E.J. Snijder, C.C. Posthuma, J. Gen. Virol. 92, 1097–1106 (2011)CrossRef PubMed PubMedCentral
  7.L. Yang, M.L. Frey, K.J. Yoon, J.J. Zimmerman, K.B. Platt, Arch. Virol. 145, 1599–1619 (2000)CrossRef PubMed
  8.W. Jiang, P. Jiang, Y. Li, J. Tang, X. Wang, S. Ma, Vet. Immunol. Immunopathol. 113, 169–180 (2006)CrossRef PubMed
  9.R.G. Bastos, O.A. Dellagostin, R.G. Barletta, A.R. Doster, E. Nelson, F. Zuckermann, F.A. Osorio, Vaccine 22, 467–474 (2004)CrossRef PubMed
  10.H.J. Qiu, Z.J. Tian, G.Z. Tong, Y.J. Zhou, J.Q. Ni, Y.Z. Luo, X.H. Cai, Vet. Immunol. Immunopathol. 106, 309–319 (2005)CrossRef PubMed
  11.L. Liu, Y. Hao, Z. Luo, Y. Huang, X. Hu, Y. Liu, Y. Shao, Vaccine 30, 4135–4143 (2012)CrossRef PubMed PubMedCentral
  12.G. Wang, F. Zhou, P. Buchy, T. Zuo, H. Hu, J. Liu, Y. Song, H. Ding, C. Tsai, Z. Chen, L. Zhang, V. Deubel, P. Zhou, J. Infect. Dis. 209, 676–685 (2014)CrossRef PubMed
  13.P.A. Dar, V.S. Suryanaryana, G. Nagarajan, G.R. Reddy, H.J. Dechamma, G. Kondabattula, Vet. Microbiol. 163, 62–70 (2013)CrossRef PubMed
  14.M. Fiedler, A. Kosinska, A. Schumann, O. Brovko, A. Walker, M. Lu, L. Johrden, A. Mayer, O. Wildner, M. Roggendorf, J. Virol. 87, 7708–7716 (2013)CrossRef PubMed PubMedCentral
  15.B. Pirzadeh, S. Dea, J. Gen. Virol. 79(Pt 5), 989–999 (1998)CrossRef PubMed
  16.C.A. Gagnon, G. Lachapelle, Y. Langelier, B. Massie, S. Dea, Arch. Virol. 148, 951–972 (2003)CrossRef PubMed
  17.P. Jiang, W. Jiang, Y. Li, S. Wu, J. Xu, Vet. Immunol. Immunopathol. 102, 321–328 (2004)CrossRef PubMed
  18.X.J. Meng, Vet. Microbiol. 74, 309–329 (2000)CrossRef PubMed
  19.W.L. Mengeling, K.M. Lager, A.C. Vorwald, K.J. Koehler, Vet. Microbiol. 93, 13–24 (2003)CrossRef PubMed
  20.T. Opriessnig, P.G. Halbur, K.J. Yoon, R.M. Pogranichniy, K.M. Harmon, R. Evans, K.F. Key, F.J. Pallares, P. Thomas, X.J. Meng, J. Virol. 76, 11837–11844 (2002)CrossRef PubMed PubMedCentral
  21.B. Pirzadeh, S. Dea, J. Gen. Virol. 78(Pt 8), 1867–1873 (1997)CrossRef PubMed
  22.K. Murata, A. Garcia-Sastre, M. Tsuji, M. Rodrigues, D. Rodriguez, J.R. Rodriguez, R.S. Nussenzweig, P. Palese, M. Esteban, F. Zavala, Cell. Immunol. 173, 96–107 (1996)CrossRef PubMed
  23.E.M. Bautista, P. Suarez, T.W. Molitor, Arch. Virol. 144, 117–134 (1999)CrossRef PubMed
  24.D.J. Shedlock, D.B. Weiner, J. Leukoc. Biol. 68, 793–806 (2000)PubMed
  25.S. Lu, Curr. Opin. Immunol. 21, 346–351 (2009)CrossRef PubMed PubMedCentral
  26.D.L. Woodland, Trends Immunol. 25, 98–104 (2004)CrossRef PubMed
  
• 作者单位：Meifang Yu (1)
  Yuan Qiu (1)
  Jiming Chen (1)
  Wenming Jiang (1)
  
  1. China Animal Health and Epidemiology Center, No. 369 Nanjing Road, Qingdao, 266032, People’s Republic of China
  
• 刊物类别：Biomedical and Life Sciences
• 刊物主题：Biomedicine
  Medical Microbiology
  Virology
  Plant Sciences
  
• 出版者：Springer Netherlands
• ISSN：1572-994X

文摘

In order to investigate the induction of humoral and cellular immune responses against porcine reproductive and respiratory syndrome virus (PRRSV), BALB/c mice were immunized in a pcDNA3-GP5 prime-rAd-GP5 boost regimen. After humoral and cellular immune response detection, levels of PRRSV-specific antibodies, neutralizing antibodies, lymphocyte proliferation response, and cytotoxic T-lymphocyte response were significantly increased as compared to controls. The humoral immune response was induced more effectively by the DNA priming and recombinant adenovirus boosting regimen. Significant difference was observed between heterogeneous and homologous vaccination. Induction of anti-GP5 antibody response was higher in all heterogeneous combinations than those of the homologous combinations. In the induction of lymphocyte proliferation response and CTL response, the homologous combination of pcDNA3-GP5/pcDNA3-GP5/pcDNA3-GP5was significantly stronger than that of rAd-GP5/rAd-GP5/rAd-GP5, but was relatively weaker than the heterogeneous combination of pcDNA3-GP5/pcDNA3-GP5/rAd-GP5 and pcDNA3-GP5/rAd-GP5/rAd-GP5. This heterogeneous combination was a most efficient immunization regimen in induction of PRRSV-specific cellular immune response just as the antibody response. These results suggested that DNA immunization followed by recombinant adenovirus boosting could be used as a potential PRRSV vaccine.